ARTICLE | Company News
Helicon, Inflazyme deal
February 12, 2001 8:00 AM UTC
The companies will develop small molecule therapeutics for age-related memory impairment and cognitive dysfunction disorders, including Alzheimer's disease. Helicon will use its in vivo models of lear...